Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1990
10/09/1990CA1275040A1 Antigens, means and method for the diagnosis of lymphadenopathy and acquired immune deficiency syndrome
10/08/1990WO1990012050A1 Chelants
10/08/1990CA2051676A1 Urokinase-type plasminogen activator receptor
10/08/1990CA2051648A1 Chelants
10/08/1990CA2014006A1 Monoclonal antibodies to tetracyclic compounds, processes for their production, and applications
10/07/1990WO1990012030A1 Rickettsial antigens for vaccination and diagnosis
10/07/1990CA2049986A1 Rickettsial antigens for vaccination and diagnosis
10/07/1990CA2014016A1 Method of immunologically assaying human thrombin-antithrombin iii complex, assay reagent and kit therefor
10/06/1990WO1990011782A2 Immunoconjugates and prodrugs and their use in association for drug delivery
10/06/1990CA2030564A1 Immunoconjugates and prodrugs and their use in association for drug delivery
10/05/1990CA2013396A1 Diagnostic method for alzheimer's disease: examination of non-neural tissue
10/05/1990CA2010835A1 Antibody purification process
10/04/1990WO1990012101A1 Vaccinia vectors, vaccinia genes and expression products thereof
10/04/1990WO1990011783A1 Platelet specific immunoconjugates
10/04/1990WO1990011360A1 POLYPEPTIDE RESULTING FROM THE FUSION BETWEEN A MALTOSE-RELATED COMPOUND (MalE) AND A CD4 FRAGMENT FOR NEUTRALIZING THE AIDS VIRUS
10/04/1990WO1990011358A1 Method for detection and/or identification of lyssavirus infections, cloning and expression of genes coding for peptides and/or fragments of peptides of mokola lyssavirus, vaccine against the mokola virus and/or the family of lyssaviruses as well as method for obtaining said vaccine via genetic engineering
10/04/1990WO1990011357A1 Early envelope glycoproteins of human cytomegalovirus (hmcv)
10/04/1990WO1990011302A1 Antibody and t cell recognition sites on glycoproteins
10/04/1990WO1990011294A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
10/04/1990WO1990011293A1 Allergenic proteins from ragweed and uses therefor
10/04/1990WO1990011289A1 Improvements relating to the radio-labelling of proteins
10/04/1990WO1990011287A1 Matrix metalloproteinase inhibitor peptides
10/04/1990WO1990011092A1 Expression of exogenous polynucleotide sequences in a vertebrate
10/04/1990WO1990011089A1 Nanbv diagnostics and vaccines
10/04/1990WO1990011088A1 Preparation of vaccines
10/04/1990WO1990011087A1 Method of preparing vaccines
10/04/1990WO1990011085A1 Large multivalent immunogen
10/04/1990WO1990011070A1 Controlled release delivery device for macromolecular proteins
10/04/1990CA2489769A1 Expression of exogenous polynucleotide sequences in a vertebrate
10/04/1990CA2357538A1 Expression of exogenous polynucleotide sequences in a vertebrate
10/04/1990CA2051436A1 Platelet specific immunoconjugates
10/04/1990CA2046909A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
10/04/1990CA2033200A1 Vaccinia vectors, vaccinia genes and expression products thereof
10/04/1990CA2013600A1 Pharmaceutical formulations
10/03/1990EP0390634A1 Hydrophobic, cross-linked, polymeric, magnetisable composite microspheres, method for their preparation and their biological uses
10/03/1990EP0390530A1 Retinoblastoma gene product antibodies and uses therefor
10/03/1990EP0390267A1 Coccidiosis vaccine
10/03/1990EP0390115A1 Monoclonal antibody NNY128
10/03/1990EP0390040A1 Ribosome inactivating proteins and derivatives thereof
10/03/1990EP0389983A2 Monoclonal antibodies to preS2 and preS1 polypeptides of the hepatitis B viral envelope
10/03/1990EP0389925A1 A method for purifying an outer membrane protein of Haemophilus influenzae
10/03/1990EP0389554A1 Immunoreactive heterochain antibodies
10/03/1990EP0389489A1 Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc
10/03/1990CN1045791A Inhibition of hiv using synergistic combinations of nucleosides derivatives
10/03/1990CA2011884A1 Selective inhibition of dna polymerase
10/02/1990CA1274794A1 Specific cea-family antigens, antibodies specific thereto and their methods of use
10/01/1990WO1990012034A1 Ribozome inactivating proteins and derivatives thereof
10/01/1990WO1990011774A1 Method of preparing a vaccine
10/01/1990CA2050592A1 Ribosome inactivating proteins and derivatives thereof
10/01/1990CA2050309A1 Method of preparing a vaccine
10/01/1990CA2049301A1 Method for treating respiratory distress syndrome
09/1990
09/30/1990CA2013572A1 Avirulent microbes and uses therefor
09/30/1990CA2013571A1 Bordetella vaccines
09/30/1990CA2013517A1 Monoclonal antibodies to pres2 and pres1 polypeptides of the hepatitis b viral envelope
09/30/1990CA2013459A1 Magnetizable composite microspheres of hydrophobic crosslinked polymer, preparation process of same and application in biology
09/29/1990CA2012676A1 Method for purifying an outer membrane protein of haemophilus influenzae
09/28/1990WO1990011091A1 FORMULATIONS FOR STABILIZING OF IgM ANTIBODIES
09/28/1990CA2049342A1 Formulations for stabilizing of igm antibodies
09/28/1990CA2013113A1 Coccidiosis vaccine
09/26/1990EP0389347A1 Vaccines against septicemic bacteria
09/26/1990EP0389286A2 Recombinant cytomegalovirus vaccine
09/26/1990EP0389034A1 Hog cholera virus vaccine and diagnostic
09/26/1990EP0388914A1 Monoclonal antibodies against tumor associated antigen, their preparation and use
09/26/1990EP0388738A1 Plasmodium merozoite rhoptries antigen and derivatives
09/26/1990EP0388434A1 Differential delivery of therapeutic agents across the blood brain barrier
09/26/1990EP0229564B1 Glycoproteins modified by oxidation followed by reduction, which inhibit ribosomes, production process and immunotoxines containing such a glycoprotein
09/26/1990EP0211014B1 Method for the immersed culture of pseudomonas aeruginosa bacterial strains
09/25/1990US4959320 Monoclonal antibody, process for preparing same, reagent for detecting cancer antigen containing the monoclonal antibody and process for preparing same
09/25/1990US4959211 Process for the production on an antiviral vaccine, particularly anti-foot and mouth disease vaccine
09/24/1990WO1990011301A1 Human macrophage migration inhibitory factor
09/24/1990WO1990011298A1 A peptide, immunogenic composition and vaccine or medicinal preparation; a method of immunising a mammal against lhrh, and a method of improving the meat quality of pigs
09/23/1990WO1990011074A1 Parathyroid hypertensive factor
09/21/1990WO1990011349A1 Vaccines for combatting septicemic bacteria
09/21/1990CA2029906A1 Vaccines for combatting septicemic bacteria
09/20/1990WO1990010707A1 Pharmaceutical product for the treatment of immunoregulatory disorders
09/20/1990WO1990010701A1 Expression system for actinomycetes and related organisms
09/20/1990WO1990010699A1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS
09/20/1990WO1990010693A1 Recombinant poxvirus host selection system
09/20/1990WO1990010461A1 A uv-induced factor for immunosuppression
09/20/1990WO1990010459A1 Pharmaceutical composition useful in the prevention or treatment of papillomavirus-induced tumours
09/20/1990WO1990010453A1 Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
09/19/1990EP0388232A1 NANBV diagnostics and vaccines
09/19/1990EP0387952A1 Primary toxic chemical compounds or allergens, which may be isolated from plant material as well as methods for their preparation and application
09/19/1990EP0387915A1 F antigens of the human immunodeficiency virus, and their applications
09/19/1990EP0387914A1 Envelope antigens of the human immuno-deficiency virus, and their applications
09/19/1990EP0387850A1 ECA-specific monoclonal antibodies and their use
09/19/1990EP0387701A1 Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
09/19/1990EP0387668A1 Intercellular adhesion molecule - 2 and its binding ligands
09/19/1990EP0192675B1 Anti-urokinase monoclonal antibody; its production and use
09/18/1990WO1990011367A1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA
09/18/1990WO1990011086A1 Production and use of anthelmintic agents and protective immunogens
09/18/1990WO1990011081A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives
09/18/1990US4958009 Anti-human ovarian cancer immunotoxins and methods of use thereof
09/18/1990US4957869 Immunogenic peptide corresponding to P. vivax CS protein
09/18/1990US4957739 Pharmaceutical compositions of a 105 kD P. Haemolytica derived antigen useful for treatment of Shipping Fever
09/18/1990US4957738 Synthetic polypeptide
09/18/1990US4957737 HTLV-III (LAV) envelope peptides
09/18/1990US4957736 Composition for vaccines
09/18/1990US4957686 Use of bacteriophages to inhibit dental caries
09/18/1990CA2305966A1 Productions and use of anthelmintic agents and protective immunogens
1 ... 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 ... 1823